menu icon

Key information
DATA SOURCE : IDP Connect

Qualification type

MSc - Master of Science

Subject areas

Oncology

Course type

Taught

Course Summary

This course will teach you about conventional cancer therapies including surgery, radiation and chemotherapy. You’ll have access to highly qualified researchers and teachers in pharmacology and immunology, as well as those from our Cellular and Molecular Immunology Research Centre. The Cancer Immunotherapy MSc will introduce you to the advancement of treatments that are fighting to prolong the lives of cancer patients. We’ll provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, as well as the current evolution of drug therapies. This will help you review the biology of cancer, taking pathological considerations into account, and the molecular changes within cells which are associated with the progression of the disease.

You’ll enhance your intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data. The teaching is delivered by highly-qualified researchers and teachers in pharmacology and immunology, including those from our Cellular and Molecular Immunology Research Centre. Skills gained from research projects will be highly marketable in industry, academia and the National Health Service (NHS), and you’ll also be encouraged to join the British Society of Immunology and the International Society of Extracellular Vesicles. Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination. As a graduate of this course, you’ll be well prepared to work for companies that are developing cancer immunotherapies. Such companies include global biopharmaceutical company Bristol-Myers Squibbs, MERCK, AstraZeneca and Roche. There are also an ever-growing number of start-up companies that are tackling cancer, including Vyriad, UNUM Therapeutics and Alpine Immune Sciences.

Different course options

Full time | Holloway | 1 year | SEP

Study mode

Full time

Duration

1 year

Start date

SEP

Modules

This module provides an understanding of the clinical aspects of oncology, focusing on diagnosis and staging of different cancers, and the range of options open for therapy.

Tuition fees

UK fees
Course fees for UK / EU students

For this course (per year)

£8,600

Average for all Postgrad courses (per year)

£5,202

International fees
Course fees for non-UK / EU students

For this course (per year)

£12,890

Average for all Postgrad courses (per year)

£12,227

Entry requirements

Students will be required to have: at least a lower second (2.2) UK first degree (or equivalent) in an appropriate subject, for example pharmacology, biomedical science, biological science or medical genetics (these will be considered on an individual basis).

University information

Whether you’re looking to change career direction, improve your job prospects or simply pursue a passion, London Met is an excellent choice for postgraduate study. The University’s graduates are working for organisations including the Bank of England, Google, Great Ormond Street Hospital and the United Nations. London Met is particularly focused on work-related learning and ensuring its students have the knowledge and skills needed for a...more

Similar courses at this uni